Your browser doesn't support javascript.
loading
Discovery of novel ß-carboline-1,2,3-triazole hybrids as AChE/GSK-3ß dual inhibitors for Alzheimer's disease treatment.
Liu, Wenjie; Tian, Liting; Wu, Limeng; Chen, Huanhua; Wang, Nan; Liu, Xin; Zhao, Changhao; Wu, Zhongchan; Jiang, Xiaowen; Wu, Qiong; Xu, Zihua; Liu, Wenwu; Zhao, Qingchun.
Affiliation
  • Liu W; Teaching Hospital of Shenyang Pharmaceutical University, General Hospital of Northern Theater Command, Shenyang 110840, People's Republic of China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
  • Tian L; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
  • Wu L; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
  • Chen H; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
  • Wang N; Teaching Hospital of Shenyang Pharmaceutical University, General Hospital of Northern Theater Command, Shenyang 110840, People's Republic of China.
  • Liu X; School of Life Science and Biochemistry, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
  • Zhao C; Teaching Hospital of Shenyang Pharmaceutical University, General Hospital of Northern Theater Command, Shenyang 110840, People's Republic of China.
  • Wu Z; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
  • Jiang X; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
  • Wu Q; Teaching Hospital of Shenyang Pharmaceutical University, General Hospital of Northern Theater Command, Shenyang 110840, People's Republic of China.
  • Xu Z; Teaching Hospital of Shenyang Pharmaceutical University, General Hospital of Northern Theater Command, Shenyang 110840, People's Republic of China; School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
  • Liu W; Teaching Hospital of Shenyang Pharmaceutical University, General Hospital of Northern Theater Command, Shenyang 110840, People's Republic of China; School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, People's Republic of China. Electronic address: sunny961010@163.com.
  • Zhao Q; Teaching Hospital of Shenyang Pharmaceutical University, General Hospital of Northern Theater Command, Shenyang 110840, People's Republic of China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China. Electronic address: zhaoq
Bioorg Chem ; 129: 106168, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36191431

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease / Neuroblastoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Bioorg Chem Year: 2022 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease / Neuroblastoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Bioorg Chem Year: 2022 Document type: Article Country of publication: United States